Celltrion
068270.KS
#771
Rank
ยฃ20.40 B
Marketcap
ยฃ98.50
Share price
1.34%
Change (1 day)
-6.13%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): ยฃ2.48

According to Celltrion 's latest financial reports the company's current EPS (TTM) is ยฃ2.37. In 2022 the company made an earnings per share (EPS) of ยฃ2.30 a decrease over its 2021 EPS that were of ยฃ2.74.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ2.487.84%
2022ยฃ2.30-15.84%
2021ยฃ2.7412.77%
2020ยฃ2.4370.79%
2019ยฃ1.4215.63%
2018ยฃ1.23-33.13%
2017ยฃ1.84141.17%
2016ยฃ0.768.28%
2015ยฃ0.7011.28%
2014ยฃ0.6316.37%
2013ยฃ0.54-67.42%
2012ยฃ1.6784.22%
2011ยฃ0.9162.13%
2010ยฃ0.5680.61%
2009ยฃ0.31-559.63%
2008-ยฃ0.06728-123.16%
2007ยฃ0.29